Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05000528
Other study ID # NIMAO/2020-2/BA-1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 30, 2022
Est. completion date September 29, 2025

Study information

Verified date January 2023
Source Centre Hospitalier Universitaire de Nimes
Contact Beatriz Abril
Phone 04.66.68.77.30
Email beatriz.abril@chu-nimes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Long waiting times for a consultation / exploration, too short a consultation period, non-reimbursement of specialists and a lack of trained staff make the current care of insomniac patients difficult. Patients are thus treated late, often with heavy drug treatment, dependence on sleeping pills, difficult withdrawal and / or reactive mood disorders. The treatment is therefore limited to advice on sleep hygiene and a restriction of time spent in bed without ultimately intervening in the cognitive domain. Therapeutic education consists of empowering the patient in the management of chronic insomnia through group education workshops. The patient learns the principles of normal sleep, the way in which sleep evolves with aging, the dangers of treatments as well as the rules of sleep hygiene and the behaviors to modify to sleep well. In addition to benefiting from sharing of experience with other patients, therapeutic education makes the care pathway smoother and considerably reduces the long waiting times of the traditional care pathway in consultation. The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date September 29, 2025
Est. primary completion date September 29, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The patient must have given their free and informed consent - The patient must be a member or beneficiary of a health insurance plan - Patient must understand and read French - Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score > 14/28. Exclusion Criteria: - Patient with cognitive impairment as assessed by the investigator - Patient with shift work - Patients scoring > 10/24 on the Epworth sleepiness scale - Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study. - Patient with chronic alcohol consumption or drug abuse - Patient unable to express consent. - Pregnant, parturient or breastfeeding patient. - The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship

Study Design


Related Conditions & MeSH terms

  • Sleep Initiation and Maintenance Disorders

Intervention

Other:
therapeutic education
In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.
Actimetry
once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention

Locations

Country Name City State
France CHU de NIMES Nimes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in chronic insomnia between groups Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion Day 28
Secondary Change in total sleeping time between groups Change in total sleeping time (minutes) from inclusion Day 28
Secondary Change in time in bed between groups Change in time in bed (minutes) from inclusion Day 28
Secondary Change in effective sleep Time between going to bed and falling asleep (minutes). Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet Day 28
Secondary Change in sleep latency % total sleeping time / time in bed. Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet Day 28
Secondary Change in intra-sleep time Change in time between going to bed and falling asleep (minutes) since inclusion, data collected from patient sleep agenda Day 28
Secondary Change in anxiety since baseline between groups State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE) reflecting the current emotional state and anxiety-trait (AT) reflecting the usual emotional state. Total score 20-80. Day 28
Secondary Change in depression since baseline between groups Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is. Day 28
Secondary Change in quality of life since baseline Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep Day 28
Secondary Use of hypnotic drugs between groups Yes/no for each type Day 28
Secondary Use of anxiolytic drugs between groups Yes/no for each type Day 28
Secondary Dose of any hypnotic drugs taken between groups Day 28
Secondary Dose of any anxiolytic drugs taken between groups Day 28
Secondary Completion of therapeutic education sessions of patients in the therapeutic education group Yes/no Day 28
Secondary Length of workshops in the therapeutic education group Minutes Day 28
Secondary Problems encountered during workshops of patients in the therapeutic education group Descriptive list made by investigator Day 28
Secondary Patient-reported reason for refusal to participate in the therapeutic education group Descriptive list of reasons given by the patient Day 28
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT01784614 - A Study of LY2624803 in Japanese Participants With Transient Insomnia Phase 1
Completed NCT00380003 - Efficacy Study of EVT 201 to Treat Insomnia Phase 2
Completed NCT00365261 - Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer Phase 4
Completed NCT00183378 - Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease N/A
Completed NCT00097604 - Effects of Valerian on Sleep in Healthy Older Adults Phase 2
Completed NCT00946530 - Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease N/A
Completed NCT00630175 - Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia Phase 3
Completed NCT00079664 - Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults Phase 1
Completed NCT00044629 - Combined Behavioral/Pharmacological Therapy for Insomnia Phase 2
Completed NCT01154023 - Behavioral Intervention for Insomnia in Older Adults N/A
Recruiting NCT04417153 - Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Recruiting NCT04986007 - Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults N/A
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT00750919 - Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007) Phase 3
Recruiting NCT04550507 - Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents N/A
Recruiting NCT05226585 - Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi) N/A